Herpes simplex virus type 1 propagation in HeLa cells interrupted by Nelumbo nucifera

Journal of Biomedical Science

Volumn 12, Issue 6, 2005, Pages 1021-1034

  Kuo, Yuh Chi ^a   Lin, Yun Lian ^b   Liu, Chih Peng ^c   Tsai, Wei Jern ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

trans induction factor C1 Oct 1 GARAT; HSV 1; ICP4; Nelumbo nucifera; NN B 5

Indexed keywords

HERBACEOUS AGENT; INFECTED CELL PROTEIN 4; MESSENGER RNA; MULTIPROTEIN COMPLEX; NELUMBO NUCIFERA EXTRACT; NN B 5; OCTAMER TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARCTIUM; ARTICLE; BIOASSAY; COIX; CYTOTOXICITY; DNA REPLICATION; DNA SYNTHESIS; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; JUJUBE; LYCIUM; MOMORDICA CHARANTIA; NELUMBO; NONHUMAN; PERSIMMON; PLATYCODON; POLYGONUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSCRIPTION; SOUTHERN BLOTTING; VIROGENESIS; VIRUS REPLICATION; YAM;

ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; BLOTTING, SOUTHERN; BLOTTING, WESTERN; DNA; DNA REPLICATION; DNA, COMPLEMENTARY; GENES, IMMEDIATE-EARLY; HELA CELLS; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; KINETICS; MEDICINE, CHINESE TRADITIONAL; MODELS, STATISTICAL; NELUMBO; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION;

ARCTIUM; COIX; DIOSCOREA ALATA; DIOSPYROS VIRGINIANA; DNA VIRUSES; HUMAN HERPESVIRUS 1; LYCIUM; MOMORDICA CHARANTIA; NELUMBO; NELUMBO NUCIFERA; PLATYCODON; POLYGONUM; ZIZIPHUS;

EID: 30544433614     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9001-6     Document Type: Article

References (43)

1. Roizman B. and Sears A.E., Herpes simplex virus and their replication, In: Fields B.N., Knipe D.M. and Howley P.M. (Eds.), Fundamental Virology. Lippincott-Raven Publishers, Philadelphia, 1996, pp. 2231-2295.
2. Pass R.F., Long W.K., Whitley R.J., Soong S.J., Diethelm A.G., Reynolds D.W. and Alford C.A. Jr., Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source kidney. J. Infect. Dis. 137: 556-563, 1978.
3. Waggoner-Fountain L.A. and Grossman L.B., Herpes simplex virus. Pediatr. Rev. 25: 86-93, 2004.
4. Stranska R., van Loon A.M., Bredius R.G., Polman M., Nienhuis E., Beersma M.F., Lankester A.C. and Schuurman R., Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child. Antivir. Ther. 9: 97-104, 2004.
5. Chen H., Teng L., Li J.N., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N. and Huang R.C., Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J. Med. Chem. 41: 3001-3007, 1998.
6. Mann S.L., Meyers J.D., Holmes K.L. and Corey L., Prevalence and incidence of herpesvirus infections among homosexually active men. J. Infect. Dis. 149: 1026-1027, 1984.
7. Corey L., Wald A., Celum C.L. and Quinn T.C.. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35: 435-445, 2004.
8. Honess R.W. and Roizman B., Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis required functional viral polypeptides. Proc. Natl. Acad. Sci. USA 72: 1276-1280, 1975.
9. McKnight J.L.C., Kristie T.M. and Roizman B., Binding of the virion protein mediating α gene induction in herpes simplex virus 1-infected cells to its cis site required cellular proteins. Proc. Natl. Acad. Sci. USA 84: 7061-7065, 1987.
10. Darby G., A history of antiherpes research. Antivir. Chem. Chemother. 5(Suppl. 1) 3-9, 1994.
11. Imai Y., Shum C.. Martin D.F., Kuppermann B.D., Drew W.L. and Margolis T.P., Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir. J. Infect. Dis. 189: 611-615, 2004.
12. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L. and Schaeffer H.J., Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. USA 74: 5716-5720, 1977.
13. Furman P.A., St. Clair M.H., Fyfe J.A., Rideout J.L., Keller P.M. and Elion G.B., Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl) guanine and its triphosphate. J. Virol. 32: 72-77, 1979.
14. Coen D.M., Antiviral drug resistance in herpes simplex virus. Adv. Exp. Med. Biol. 394: 49-57, 1996.
15. Kimberlin D.W. and Whitley R.J., Antiviral resistance: mechanisms, clinical significance, and future implications. J. Antimicrob. Chemother. 37: 403-421, 1996.
16. Chibo D., Druce J., Sasadeusz J. and Birch C., Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antivir. Res. 61: 83-91, 2004.
17. Kuo Y.C., Yang N.S., Chou C.J., Lin L.C. and Tsai W.J., Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura. Mol. Pharmacol. 58: 1057-1066, 2000.
18. Kuo Y.C., Sun C.M., Ou J.C. and Tsai W.J., A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci. 61: 2335-2344, 1997.
19. Marchetti M., Pisani S., Pietropaola V., Seganti L., Nicoletti R., Degener A. and Orsi N., Antiviral effect of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus type 1 infection. Planta Medica 62: 303-307, 1996.
20. Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H. and Blomster R.N., Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 35: 2463-2466, 1991.
21. Simõnes C.M.O., Amoros M. and Girre L., Mechanism of antiviral activity of triterpenoid saponins. Phytother Res. 21: 317-325, 1999.
22. Arisawa M., Fujita A., Hayashi T., Hayashi K., Ochiai H. and Morita N., Cytotoxic and antiherpetic activity of phloroglucinol derivatives from Mallotus japonicus (Euphorbiaceae). Chem. Pharm. Bull. 38: 1624-1626, 1990.
23. Kuo Y.C., Lin L.C., Tsai W.J., Chou C.J., Kung S.H. and Ho Y.H., Samaragenin B identified from Limonium sinense suppressed herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis. Antimicrob. Agents Chemother. 46: 2854-2864, 2002.
24. Ferrea G., Canessa A., Sampietro F., Cruciani M., Romussi G. and Bassetti D., In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2. Antivir. Res. 21: 317-325, 1993.
25. Alrabiah F.A. and Sacks S.L., New antiherpes virus agents: their targets and therapeutic potential. Drugs 52: 17-32, 1996.
26. Pope L.E., Marceletti J.F., Katz L.R. and Katz D.H., Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug. J. Lipid Res. 37: 2167-2178, 1996.
27. Sacks S.L., Thisted R.A., Jones T.M., Barbarash R.A., Mikolich D.J., Ruoff G.E., Jorizzo J.L., Gunnill L.B., Katz D.H., Khalil M.H., Morrow P.R.G., Yakatan J., Pope L.E. and Berge J.E., The Docosanol 10% Cream Study Group. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J. Am. Acad. Dermatol. 45: 222-230, 2001.
28. Betz U.A.K., Fischer R., Kleymann G., Hendrix M. and Rübsamen- Waigmann H., Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrob. Agents Chemother. 46: 1766-1772, 2002.
29. Kleymann G., Fischer R., Betz U.A.K., Hendrix M., Bender W., Schneider U., Handke G., Eckenberg P., Hewlett G., Pevzner V., Baumeister J., Weber O., Henninger K., Keldenich J., Jensen A., Kolb J., Bach I., Popp A., Mäben J., Frappa I., Haebich D., Lockhoff O. and Rübsamen-Waigmann H., New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med. 8: 392-398, 2002.
30. Kuo Y.C., Chen C.C., Tsai W.J. and Ho Y.H., Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: relationship to gene expression, DNA replication, and protein synthesis. Antivir. Res. 51: 95-109, 2001.
31. Kuo Y.C., Liu W.T. and Lin C.Y., Herpes simplex virus type 1 genes in human mononuclear cells and affecting cell-mediated immunity. J. Med. Virol. 41: 138-145, 1993.
32. Saiki P.K., Scharf S., Faloona F., Mullis K.B., Horn G., Erlich H.A. and Arnheim N., Enzymatic amplification of globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350-1354, 1985.
33. Cone R.W., Hobson A.C., Palmer J., Remington M. and Corey L., Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J. Infect. Dis. 164: 757-760, 1991.
34. Bacon T.H., Howard B.A., Spender L.C. and Boyd M.R., Activity of penciclovir in antiviral assays against herpes simplex virus. J. Antimicrob. Chemother. 37: 303-313, 1996.
35. Qian J.Q., Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacol. Sin. 23: 1086-1092, 2002.
36. Yu J. and Hu W.S., Effects of neferine on platelet aggregation in rabbits. Yao Xue Xue Bao 32: 1-4, 1997.
37. Mackem S. and Roizman B., Structural features of the herpes simplex alpha gene 4, 0, 27 promoter-regulatory sequences which confer a regulation on chimeric thymidine kinase genes. J. Virol. 44: 939-949, 1982.
38. Jones P.C. and Roizman B., Regulation of herpesvirus macromolecular synthesis: VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated. J. Virol. 31: 299-314, 1979.
39. Honess R.W. and Roizman B., Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14: 8-19, 1974.
40. Hoshino T., Hayashi T., Hayashi K., Hamada J., Lee J.B. and Sankawa U., An antivirally active sulfated polysaccharide from Sargassum horneri (Turner) C. Agardh. Biol. Pharm. Bull. 21: 730-734, 1998.
41. Boulware S.L., Bronstein J.C., Nordby E.C. and Weber P.C., Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antivir. Res. 51: 111-125, 2001.
42. Kramer M.F. and Coen D.M., Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69: 1389-1399, 1995.
43. Feldman L.T., Ellison A.R., Voytek C.C., Yang L., Krause P. and Margolis T.P., Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99: 978-983, 2002.